Dermatology

Filter

PARP Inhibitor Shows Promise in Advanced Melanoma Treatment

July 2025

The study highlights how HR pathway alterations, which affect roughly a fifth to a third of melanomas, may offer an opportunity for targeted treatment.

Maternal Probiotics May Lower Infant Eczema Risk

Findings suggest that probiotics’ ability to reduce the risk of atopic eczema may not depend on significant changes in gut microbiota.

New Evidence Supports Tildrakizumab for Scalp Psoriasis

Patients initially receiving placebo experienced notable improvement after switching to tildrakizumab.

New Study Uncovers Key Mechanisms in Psoriasis

Recent findings indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following treatment.

A New Way to Improve Melanoma Immunotherapy

Leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Which Treatment for Basal Cell Carcinoma is More Effective?

After five years, the probability of remaining free from treatment failure was 77.8% for patients who underwent superficial curettage.

AI-Powered Sensor Helps Reduce Nocturnal Scratching

While numerous pharmacological treatments for atopic dermatitis exist, there is a scarcity of effective nonpharmacological interventions.

New Approach Lowers Pemphigus Relapse Risk with Additional Rituximab

A targeted rituximab infusion at 6 months, based on relapse predictors, significantly reduced pemphigus recurrence at one year.

Neoadjuvant T-VEC Shows Promise for Difficult-to-Treat Basal Cell Carcinoma

Neoadjuvant T-VEC achieves resectability in 50% of difficult-to-treat BCC cases, improving outcomes without extensive reconstructive surgery.

Loading posts...

« Previous 1 … 5 6 7 8 9 … 31 Next »